Author

Abbass Jaber

InsermORCID 0009-0005-5015-9911Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

Isabelle RichardiD· 2 shared Nathalie BourgiD· 2 shared Sonia AlbiniiD· 2 shared Adeline Miranda· 1 shared Ai Vu HongiD· 1 shared Alan Dorval· 1 shared Auriane Dubois· 1 shared Carinne RoudautiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Isabelle RichardORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GeneticsDisease Models & MechanismsPeer-reviewedJan 1, 2026

A NEW DYSTROPHIN DEFICIENT RAT MODEL MIRRORING EXON SKIPPING IN PATIENTS WITH DMD EXON 45 DELETIONS

Tao Wang, Cynthia Daoud, Auriane Dubois…·Isabelle Richard

This paper describes a novel rat model with an exon 45 deletion in the Dmd gene, showing features of DMD and exon skipping, which may inform personalized therapies.

2 citations

ratbulk RNA-seq

𝕏 PostBluesky

PhysiologybioRxivPreprintFeb 11, 2025

Targeting lysosomal damage is a new therapeutic perspective for Duchenne Muscular Dystrophy

Abbass Jaber, Laura Palmieri, Rania Bakour…·David Israeli

This study identifies lysosomal damage as a novel mechanism in Duchenne Muscular Dystrophy and shows that combining trehalose with gene therapy improves outcomes.

DOI 10.1101/2025.02.11.637610

mousebulk RNA-seq

𝕏 PostBluesky